Leopold, Lance
Fox Chase Cancer Center · University of Connecticut · University of Michigan · University of Chicago · Angeles Clinic and Research Institute · Tennessee Oncology · University of Pennsylvania
2 papers on CoChat
Most cited papers
- Verified
Epacadostat plus pembrolizumab in patients with advanced solid tumors: phase I results from a multicenter, open-label phase I/II trial (ECHO-202/KEYNOTE-037)
Mitchell, T. C., Hamid, O., Smith, D. C., Bauer, T. M., Wasser, J. S., Olszanski, A. J., Luke, J. J., Balmanoukian, A. S., Schmidt, E. V., Zhao, Y., et al. (2018) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 388
- Verified
First-in-human phase I study of the oral inhibitor of indoleamine 2,3-dioxygenase-1 epacadostat (INCB024360) in patients with advanced solid malignancies
Beatty, G. L., O'Dwyer, P. J., Clark, J., Shi, J. G., Bowman, K. J., Scherle, P. A., Newton, R. C., Schaub, R., Maleski, J., Leopold, L., et al. (2017) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 314
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free